Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Hims & Hers Health, Inc. (HIMS) Reports Q4 Loss of $0.07 on Revenues of $41.7M; Offers 1Q & FY21 Revenues Guidance
March 18, 2021 4:10 PM EDTHims & Hers Health, Inc. (NYSE: HIMS) reported Q4 EPS of ($0.07), versus ($0.16) reported last year. Revenue for the quarter came in at $41.47 million, versus $41.32 million reported last year.
We closed out this important year for Hims & Hers on a high note, meeting or exceeding the expectations for 2020 performance in our roadshow this past fall, including 80% revenue growth year-over-year and improved gross margins, said Andrew Dudum, CEO and co-founder of Hims & Hers. We also made smart... More
